Yu-Kai Li

Title: Innovations of Yu-Kai Li in Pharmaceutical Chemistry

Introduction

Yu-Kai Li is a notable inventor based in Taoyuan County, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on morphinan derivatives. His research has led to advancements that may impact the development of new pharmaceutical compositions.

Latest Patents

Yu-Kai Li holds a patent for "Crystals of morphinan derivative, manufacturing method thereof, and pharmaceutical composition using the same." This invention pertains to an X-form crystal of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[N-methyl-trans-3-(3-furyl)acrylamido]morphinan hydrochloride. The patent details the manufacturing method of this compound, which exhibits characteristic diffraction peaks at specific positions in a powder X-ray diffraction pattern. This innovation is crucial for the development of pharmaceutical compositions that utilize this morphinan derivative.

Career Highlights

Yu-Kai Li is associated with Everlight Chemical Industrial Corporation, where he continues to engage in research and development. His work has not only contributed to his personal achievements but has also enhanced the company's portfolio in the pharmaceutical sector.

Collaborations

He collaborates with talented coworkers such as Yuan-Yi Wang and Yu-Ting Su, contributing to a dynamic research environment that fosters innovation and creativity.

Conclusion

Yu-Kai Li's contributions to pharmaceutical chemistry through his patent on morphinan derivatives exemplify the importance of innovation in the field. His work has the potential to influence future pharmaceutical developments significantly.